Please note: This trial has finished recruiting and is not accepting new participants.

Research Center: Q-Pharm Pty Limited
Location: 300C Herston Road, Herston, Brisbane 4006 (shown on map)
Lead Doctor: Dr Paul Griffin
Ethics Committee: Reviewed and approved by the QIMR Berghofer Medical Research Institute Human Research Ethics Committee

Background

It is estimated that 1 in 8 Australians have genital herpes, a disease which often causes recurrent outbreaks of painful sores and lesions.

Once a person is infected, the herpes virus is spread during outbreaks of sores and lesions and can also be transmitted when there are no visible symptoms. Currently, there is no vaccine on the market to prevent or reduce occurrences of genital herpes outbreaks and there is a clear need for new treatments to improve the quality of life of people with the disease and to prevent transmission.

In this study, a potential vaccine for the treatment of genital herpes caused by the Herpes Simplex Virus type 2 will be investigated. This study will be the second clinical trial where this vaccine has been given to participants.

Benefits of Participation

• Your current health will be assessed.
• You will be have the opportunity to find out how often you are infectious (with or without symptoms) during certain stages of the study, and be able to discuss this with a health professional.
• You could see a reduction in the number of your outbreaks. But note, you will have a one in four chance of receiving placebo. Placebo is a medication with no active ingredients or procedure without any medical benefit.
• Qualified health professionals will monitor your health.
• You will be helping to advance medical research.

Your Rights

• If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time and for any reason.
• Your records relating to this study and any other information received will be kept strictly confidential.
• Upon completion, the results of the study will be shared with you.

Who Can Participate?

• Men and Women aged 18 to 50, who:
  • Have a history of recurrent Genital Herpes, and
  • Are able to attend the clinic within 24-hours of developing an outbreak
  • Are able to attend clinic for multiple visits over a year.